Altered metabolism of all-trans-retinoic acid in liposome-encapsulated form
- 1 December 1998
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 134 (2) , 121-128
- https://doi.org/10.1016/s0304-3835(98)00226-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1993
- 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the CervixJNCI Journal of the National Cancer Institute, 1992
- 13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the SkinJNCI Journal of the National Cancer Institute, 1992
- Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]Blood, 1992
- A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patientsBlood, 1991
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Multistep Process of Squamous Differentiation of Tracheobronchial Epithelial Cells: Role of RetinoidsDermatology, 1987
- Liposomes as drug carriers in cancer chemotherapyPharmacology & Therapeutics, 1984